Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Elixir Department: SOP for Prevention of Aeration During Mixing – V 2.0

Posted on By

Elixir Department: SOP for Prevention of Aeration During Mixing – V 2.0

Standard Operating Procedure for Prevention of Aeration During Mixing in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/067/2025
Supersedes SOP/ELX/067/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a systematic procedure for preventing aeration during the mixing of elixir formulations, which can lead to product instability, foaming, oxidation, and dosing inconsistencies.

2. Scope

This SOP applies to all mixing processes involved in elixir manufacturing where aeration control is critical to maintaining product quality and uniformity.

3. Responsibilities

  • Manufacturing Operator:
    • Operate mixing equipment in a manner that minimizes air entrapment.
    • Follow mixing speed and agitation sequence as per BMR instructions.
  • Production Supervisor:
    • Ensure equipment design and mixing parameters are aeration-safe.
    • Verify agitation speed and impeller settings.
  • QA Officer:
    • Monitor visual indicators of aeration (bubbles, foam) during mixing and ensure compliance to SOP.
See also  Elixir Department: SOP for Use of Barcode Systems During Dispensing - V 2.0

4. Accountability

The Production Head is accountable for ensuring that all mixing operations are carried out in a manner that avoids aeration and preserves product quality.

5. Procedure

5.1 Equipment and Setup

  1. Use bottom-entry or low-shear mixers whenever possible to minimize vortex formation.
  2. Ensure impellers are properly positioned and not exposed above the liquid surface.
  3. Ensure tanks are filled to at least 70% of their working capacity before initiating high-speed mixing.

5.2 Agitation Control

  1. Start mixing at low RPM (e.g., 20–40) and gradually increase if necessary.
  2. Avoid vigorous agitation at low liquid volumes to prevent vortexing.
  3. Monitor vortex depth visually; it should not exceed 1/4 of liquid depth.
  4. If a vortex forms, reduce speed immediately and adjust impeller depth.

5.3 Addition of Ingredients

  1. Add powders or concentrates slowly into the vortex area or through a submerged funnel to reduce splashing and air intake.
  2. For volatile or foaming agents (e.g., surfactants, ethanol), reduce agitation to minimal levels during addition.
  3. Keep vessel covered during addition to reduce air turbulence.
See also  Elixir Department: SOP for Preparation of Manufacturing Tank - V 2.0

5.4 Visual Inspection

  1. Check for presence of bubbles, foam, or milky consistency.
  2. If foam is observed:
    • Pause mixing and allow solution to settle.
    • Skim off foam if necessary using sterile utensils.
  3. Document findings and corrective actions in the Aeration Control Log (Annexure-1).

5.5 Post-Mixing Measures

  1. Allow batch to stand for at least 15 minutes post-mixing before filtration to allow trapped air to escape.
  2. Do not proceed to filtration or filling if signs of aeration persist.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • RPM: Revolutions Per Minute

7. Documents

  1. Aeration Control Log (Annexure-1)
  2. Mixing Parameter Sheet (Annexure-2)
  3. Foam Observation Checklist (Annexure-3)

8. References

  • WHO GMP Guidelines for Liquid Oral Preparations
  • ICH Q8(R2) – Pharmaceutical Development
See also  Elixir Department: SOP for Use of Approved Dispensing Aids and Equipment - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Aeration Control Log

Date Batch No. Observed Issue Corrective Action Operator Verified By
11/04/2025 ELX-1012 Foam formation Agitation stopped, foam removed Rajesh Kumar Sunita Reddy

Annexure-2: Mixing Parameter Sheet

Batch No. Start Time End Time RPM Impeller Type Remarks
ELX-1012 09:00 AM 09:45 AM 60 Anchor No vortex

Annexure-3: Foam Observation Checklist

Time Observation Action Taken Checked By
09:45 AM Minimal foam present Allowed to settle Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New SOP QA Head
11/04/2025 2.0 Included Vortex Depth Limit and Foam Checklist Process Optimization QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Analytical Method Development: Selection of HPLC Column and Mobile Phase – V 2.0
Next Post: Aerosol: SOP for Maintaining Equipment Logbooks in Aerosol Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version